 Irish Medical Times | Study favours infliximab, but 'jury is still out' Irish Medical Times Evidence favouring infliximab over cyclosporine for the treatment of steroid-refractory ulcerative colitis has been bolstered by research showing that its use results in improved clinical outcomes and fewer adverse events. Studies into the two drugs ... |
